HLFNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
HERBALIFE LTD.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$13.88−0.72 (-4.93%)
Close on Oct 19, 2026
- Market cap
- $1.45B
- P/E (TTM)
- 9.0
- Dividend yield
- –
Share price
+$5.11 (+58.27%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
HERBALIFE LTD. grew revenue 5.5% to $5.20B over the twelve months to Jun 30, 2026. Operating income rose 0.7% to $492.30M, moving the operating margin from 9.9% to 9.5%. Free cash flow was $322.30M, up 88.0% from a year earlier.
Revenue
$5.20B
+5.5% vs. a year earlier
Operating income
$492.30M
+0.7% vs. a year earlier
Free cash flow
$322.30M
+88.0% vs. a year earlier
EPS, diluted
$1.55
-51.1% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.45B
- P/E ratio
- 9.0
- Price to sales
- 0.28
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- 22.22%
Fundamentals
- Revenue
- $5.20B
- Net income
- $164.20M
- EPS, diluted
- $1.55
- Free cash flow
- $322.30M
- Book value per share
- -$4.54
- Diluted shares
- 105M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$5.20B+5.5% YoY
Gross profit
$4.04B+5.0% YoY
Operating income
$492.30M+0.7% YoY
Net income
$164.20M-49.5% YoY
EPS, diluted
$1.55-51.1% YoY
Free cash flow
$322.30M+88.0% YoY
Reported periodTrailing twelve months